Summit Therapeutics (SMMT) Enterprise Value (2017 - 2026)
Summit Therapeutics' Enterprise Value was $10.87 billion in Q2 2026, down 29.9% from $15.51 billion a year earlier and down 23.0% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Enterprise Value (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Summit Therapeutics' Enterprise Value was $9.31 billion through Jun 30, 2026, down 34.6% year-over-year; for FY2025, it was $12.85 billion, up 0.8% from FY2024.
- Enterprise Value has now increased for four consecutive years, with a five-year compound annual growth rate of 109.1% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $12.75 billion in FY2024 (+674.8%), $1.65 billion in FY2023 (+199.9%), $548.53 million in FY2022 (+185.8%) and $191.94 million in FY2021 (-40.3%).
- The Q2 2026 figure marks the lowest quarterly Enterprise Value since Q2 2024.
- Compared with a year earlier, Enterprise Value was higher in five of the last seven quarters, with growth averaging 177.4%.
- The best year-over-year quarter for Enterprise Value over five years was Q4 2024 (growth of 674.8%); the worst was Q3 2022 (a decline of 88.8%).
- Per Business Quant data, SMMT's Enterprise Value in the three quarters before Q2 2026 was $14.11 billion (Q1 2026), $12.85 billion (Q4 2025) and $15.14 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Summit Therapeutics | 12.28 Bn | 10.04 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.87 Bn |
| Mar 31, 2026 | 14.11 Bn |
| Dec 31, 2025 | 12.85 Bn |
| Sep 30, 2025 | 15.14 Bn |
| Jun 30, 2025 | 15.51 Bn |
| Mar 31, 2025 | 13.94 Bn |
| Dec 31, 2024 | 12.75 Bn |
| Sep 30, 2024 | 15.66 Bn |
| Jun 30, 2024 | 5.32 Bn |
| Mar 31, 2024 | 2.75 Bn |
| Dec 31, 2023 | 1.65 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 419.85 Mn |
| Dec 31, 2022 | 548.53 Mn |
| Sep 30, 2022 | 54.84 Mn |
| Jun 30, 2022 | 98.12 Mn |
| Mar 31, 2022 | 240.40 Mn |
| Dec 31, 2021 | 191.94 Mn |
| Sep 30, 2021 | 489.12 Mn |
API Access
Summit Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();